2024.9


Release time:

2025-01-10

Nanolattix Submits Dual IND Applications for Cancer Drug T320 in China and the U.S

2024.9

Nanolattix Submits Dual IND Applications for Cancer Drug T320 in China and the U.S

Tag:


Previous Page

Next Page

Previous Page:

Next page: